Emerging Biotech · Gene Therapy
Breaking perceptions of TFF in gene therapy manufacturing
The tangential flow filtration (TFF) unit operation in viral vector manufacturing is a critical step on the path…
Ratish Krishnan
Ratish Krishnan is a Senior Strategy Consultant in the Novel Modalities BioProcessing group for the Americas. He is passionate about providing solutions to bring treatments to market. A Process Development Scientist by background, he has over 13 years of experience in vaccine, monoclonal antibodies and viral vector modalities from pre-clinical to late stage process characterization, validation and commercialization activities such as BLA authoring.
Gene Therapy
Innovative Trends That Drive AAV Capture and Empty-Full Separation
Ratish Krishnan and Oliver Rammo share their thoughts on the need for a more nuanced understanding of AAV…
